4//SEC Filing
DEMANE MICHAEL F 4
Accession 0001140361-23-016281
CIK 0001444380other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:43 PM ET
Size
8.0 KB
Accession
0001140361-23-016281
Insider Transaction Report
Form 4
NEVRO CORPNVRO
DEMANE MICHAEL F
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2023-03-31+726→ 20,727 total
Holdings
- 18,266(indirect: See footnote)
Common Stock
- 164,344(indirect: See footnote)
Common Stock
- 82,541(indirect: See footnote)
Common Stock
- 91,225(indirect: See footnote)
Common Stock
Footnotes (6)
- [F1]Fully vested restricted stock. The restricted stock represent quarterly retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash.
- [F2]Includes 4,155 restricted stock units.
- [F3]Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012.
- [F4]Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2017 Family SLAT Trust U/A/D May 22, 2017.
- [F5]Shares held by Michael F. DeMane & Catherine Q. DeMane, Trustees, Michael F. DeMane Revocable Trust U/A 10/07/2011.
- [F6]Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2021 Retained Annuity Trust U/A 08/13/2021.
Documents
Issuer
NEVRO CORP
CIK 0001444380
Entity typeother
Related Parties
1- filerCIK 0001174533
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 4:43 PM ET
- Size
- 8.0 KB